Pharicin B, also isolated from I. pharicus, has been shown to stabilize the retinoic acid receptor-a (RAR-a) and synergistically enhances differentiation in several AML cell lines, particularly in some primary acute promyelocytic leukemia (APL) cell lines, when used in combination with ATRA. The gene discussed is RARA; the disease is acute promyelocytic leukemia.